Rifampicin decreases neuroinflammation to maintain mitochondrial function and calcium homeostasis in rotenone-treated zebrafish

References

• Alegre-Abarrategui, J., et al., 2019. Selective vulnerability in α-synucleinopathies. Acta Neuropathologica, 138 (5), 681–704.
   PubMed Web of Science ®Google Scholar
• Bi, W., et al., 2013. Rifampicin and Parkinson’s disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 34 (2), 137–141.
   PubMed Web of Science ®Google Scholar
• Bové, J., et al., 2005. Toxin-induced models of Parkinson’s disease. NeuroRx : The Journal of the American Society for Experimental Neurotherapeutics, 2 (3), 484–494.
   PubMedGoogle Scholar
• Bretaud, S., Lee, S., and Guo, S., 2004. Sensitivity of zebrafish to environmental toxins implicated in Parkinson’s disease. Neurotoxicology and Teratology, 26 (6), 857–864.
   PubMed Web of Science ®Google Scholar
• Cannon, J.R., et al., 2009. A highly reproducible rotenone model of Parkinson’s disease. Neurobiology of Disease, 34 (2), 279–290.
   PubMed Web of Science ®Google Scholar
• Chen, D., et al., 2003. Identification of a nuclear protein that promotes NF-kappaB activation. Biochemical and Biophysical Research Communications, 310 (3), 720–724.
   PubMed Web of Science ®Google Scholar
• Choi, I.Y., et al., 2013. 4-Hydroxy-2(E)-nonenal facilitates NMDA-induced neurotoxicity via triggering mitochondrial permeability transition pore opening and mitochondrial calcium overload. Experimental Neurobiology, 22 (3), 200–207.
   PubMedGoogle Scholar
• De Pinto, V., et al., 2010. Voltage-dependent anion-selective channel (VDAC) in the plasma membrane. FEBS Letters, 584 (9), 1793–1799.
   PubMed Web of Science ®Google Scholar
• Ding, W.X., et al., 2010. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. The Journal of Biological Chemistry, 285 (36), 27879–27890.
   PubMed Web of Science ®Google Scholar
• Fields, C.R., Bengoa-Vergniory, N., and Wade-Martins, R., 2019. Targeting alpha-synuclein as a therapy for Parkinson’s disease. Frontiers in Molecular Neuroscience, 12, 299.
   PubMed Web of Science ®Google Scholar
• Flood, P.M., et al., 2011. Transcriptional factor NF-κB as a target for therapy in Parkinson’s disease. Parkinson’s Disease, 2011, 216298.
   PubMed Web of Science ®Google Scholar
• Francardo, V., 2014. Sigma-1 receptor: a potential new target for Parkinson’s disease? Neural Regeneration Research, 9 (21), 1882–1883.
   PubMed Web of Science ®Google Scholar
• Franco, R., et al., 2010. Molecular mechanisms of pesticide-induced neurotoxicity: relevance to Parkinson’s disease. Chemico-Biological Interactions, 188 (2), 289–300.
   PubMed Web of Science ®Google Scholar
• Frank-Cannon, T.C., et al., 2008. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 28 (43), 10825–10834.
   PubMed Web of Science ®Google Scholar
• Frei, B. and Richter, C., 1986. N-Methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria. FEBS Letters, 198 (1), 99–102.
   PubMed Web of Science ®Google Scholar
• Ghiglieri, V., Calabrese, V., and Calabresi, P., 2018. Alpha-synuclein: from early synaptic dysfunction to neurodegeneration. Frontiers in Neurology, 9, 295.
   PubMed Web of Science ®Google Scholar
• Hayashi, T. and Su, T.P., 2007. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell, 131 (3), 596–610.
   PubMed Web of Science ®Google Scholar
• Hirsch, E.C., Hunot, S., and Hartmann, A., 2005. Neuroinflammatory processes in Parkinson’s disease. Parkinsonism & Related Disorders, 11 Suppl 1, S9–S15.
   PubMed Web of Science ®Google Scholar
• Hisahara, S. and Shimohama, S., 2011. Toxin-induced and genetic animal models of Parkinson’s disease. Parkinson’s Disease, 2011, 951709.
   Web of Science ®Google Scholar
• Jin, H., et al., 2014. Mitochondria-targeted antioxidants for treatment of Parkinson’s disease: preclinical and clinical outcomes. Biochimica et Biophysica Acta, 1842 (8), 1282–1294.
   PubMed Web of Science ®Google Scholar
• Kett, L.R. and Dauer, W.T., 2016. Endolysosomal dysfunction in Parkinson’s disease: recent developments and future challenges. Movement Disorders : Official Journal of the Movement Disorder Society, 31 (10), 1433–1443.
   PubMed Web of Science ®Google Scholar
• Leonard W.J., Wan C.K., 2016. IL-21 signaling in immunity. F1000Research, 5:F1000.
   Google Scholar
• Li, D., et al., 2013. Alteration of dynein function affects α-synuclein degradation via the autophagosome-lysosome pathway. International Journal of Molecular Sciences, 14 (12), 24242–24254.
   PubMed Web of Science ®Google Scholar
• Lytton, J., et al., 2002. K+-dependent Na+/Ca2+ exchangers in the brain. Annals of the New York Academy of Sciences, 976, 382–393.
   PubMed Web of Science ®Google Scholar
• Milanese, C., et al., 2012. Hypokinesia and reduced dopamine levels in zebrafish lacking β- and γ1-synucleins. The Journal of Biological Chemistry, 287 (5), 2971–2983.
   PubMed Web of Science ®Google Scholar
• Nguyen, L., et al., 2015. Role of sigma-1 receptors in neurodegenerative diseases. Journal of Pharmacological Sciences, 127 (1), 17–29.
   PubMed Web of Science ®Google Scholar
• Oida, Y., et al., 2006. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain. Brain Research, 1082 (1), 196–204.
   PubMed Web of Science ®Google Scholar
• Okatsu, K., et al., 2010. p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes to Cells : Devoted to Molecular & Cellular Mechanisms, 15 (8), 887–900.
   PubMed Web of Science ®Google Scholar
• Omura, T., et al., 2013. Endoplasmic reticulum stress and Parkinson’s disease: the role of HRD1 in averting apoptosis in neurodegenerative disease. Oxidative Medicine and Cellular Longevity, 2013, 239854.
   PubMed Web of Science ®Google Scholar
• Pickrell, A.M. and Youle, R.J., 2015. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease. Neuron, 85 (2), 257–273.
   PubMed Web of Science ®Google Scholar
• Reynolds, A.D., et al., 2008. Nitrated alpha-synuclein-activated microglial profiling for Parkinson’s disease. Journal of Neurochemistry, 104 (6), 1504–1525.
   PubMed Web of Science ®Google Scholar
• Ruscher, K. and Wieloch, T., 2015. The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration. Journal of Pharmacological Sciences, 127 (1), 30–35.
   PubMed Web of Science ®Google Scholar
• Shoshan-Barmatz, V., et al., 2004. Subcellular localization of VDAC in mitochondria and ER in the cerebellum. Biochimica Et Biophysica Acta (BBA)- Bioenergetics, 1657 (2-3), 105–114.
   PubMed Web of Science ®Google Scholar
• Shoshan-Barmatz, V., et al., 2010. VDAC, a multi-functional mitochondrial protein regulating cell life and death. Molecular Aspects of Medicine., 31 (3), 227–285.
   PubMed Web of Science ®Google Scholar
• Sidhu, A., et al., 2004. The role of alpha-synuclein in both neuroprotection and neurodegeneration. Annals of the New York Academy of Sciences, 1035, 250–270.
   PubMed Web of Science ®Google Scholar
• Sousa, S.C., et al., 2003. Ca2+-induced oxidative stress in brain mitochondria treated with the respiratory chain inhibitor rotenone. FEBS Letters, 543 (1-3), 179–183.
   PubMed Web of Science ®Google Scholar
• Sun, Y., et al., 2012. Voltage-dependent anion channels (VDACs) recruit Parkin to defective mitochondria to promote mitochondrial autophagy. The Journal of Biological Chemistry, 287 (48), 40652–40660.
   PubMed Web of Science ®Google Scholar
• Surmeier, D.J. and Schumacker, P.T., 2013. Calcium, bioenergetics, and neuronal vulnerability in Parkinson’s disease. The Journal of Biological Chemistry, 288 (15), 10736–10741.
   PubMed Web of Science ®Google Scholar
• Ünal, İ. and Emekli-Alturfan, E., 2019. Fishing for Parkinson’s Disease: a review of the literature. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 62, 1–6.
   PubMed Web of Science ®Google Scholar
• Ünal, İ., et al., 2019. Rotenone impairs oxidant/antioxidant balance both in brain and intestines in zebrafish. The International Journal of Neuroscience, 129 (4), 363–368.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2017. Parkinson’s disease-like motor and non-motor symptoms in rotenone-treated zebrafish. Neurotoxicology, 58, 103–109.
   PubMed Web of Science ®Google Scholar
• Wang, X.J. and Xu, J.X., 2005. Possible involvement of Ca2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neuroscience Letters, 376 (2), 127–132.
   PubMed Web of Science ®Google Scholar
• Wilson, J.M., Bunte, R.M., and Carty, A.J., 2009. Evaluation of rapid cooling and tricaine methanesulfonate (MS222) as methods of euthanasia in zebrafish (Danio rerio). Journal of the American Association for Laboratory Animal Science : JAALAS, 48 (6), 785–789.
   PubMed Web of Science ®Google Scholar
• Tsoulfas, G. and Geller, D.A., 2001. NF-kappaB in transplantation: friend or foe? Transplant Infectious Disease : An Official Journal of the Transplantation Society, 3 (4), 212–219.
   PubMedGoogle Scholar
• Zakharov, S.D., et al., 2007. Helical alpha-synuclein forms highly conductive ion channels. Biochemistry, 46 (50), 14369–14379.
   PubMed Web of Science ®Google Scholar